Nature Communications (Feb 2018)
Chiral DOTA chelators as an improved platform for biomedical imaging and therapy applications
Abstract
MRI contrast agents containing the rare earth metal gadolinium are very effective, yet unstable and thus potentially hazardous. Here, the authors developed complexes between gadolinium and the scaffolding compound DOTA with increased stability, which also lend themselves to radiometal labelling.